Zyprexa and Decreased interest - a phase IV clinical study of FDA data
Summary:
Decreased interest is reported as a side effect among people who take Zyprexa (olanzapine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Pain.
The phase IV clinical study analyzes which people have Decreased interest when taking Zyprexa. It is created by eHealthMe based on reports of 63,412 people who have side effects when taking Zyprexa from the FDA, and is updated regularly.
What is Zyprexa?
Zyprexa has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 64,722 Zyprexa users. Check the latest studies of Zyprexa.
What is Decreased interest?
Decreased interest is found to be associated with 936 drugs and 951 conditions by eHealthMe. Check the latest studies of Decreased interest.
63,412 people reported to have side effects when taking Zyprexa.
Among them, 118 people (0.19%) have Decreased interest.
Among these 118 people:
How long have people been on Zyprexa when they have Decreased interest? *
What is the gender of people who have Decreased interest when taking Zyprexa? *
What is the age of people who have Decreased interest when taking Zyprexa? *
What are other drugs people take besides Zyprexa? *
What are other side effects people have besides Decreased interest? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Zyprexa and have Decreased interest?
- Check whether Decreased interest is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Zyprexa:
- Zyprexa (64,722 reports)
Decreased interest treatments and more:
- Decreased interest (8,726 reports)
How severe was Decreased interest and when was it recovered:
Expand to all the drugs that have ingredients of olanzapine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Zyprexa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Decreased interest:
- Decreased interest (936 drugs)
Browse all the conditions that are associated with Decreased interest:
- Decreased interest (951 conditions)
Related publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on olanzapine (the active ingredients of Zyprexa) and Zyprexa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Valtrex cause Fibromyalgia? - 9 seconds ago
- Could Detrol cause Pulmonary Embolism? - 9 seconds ago
- Could Simvastatin cause Hyperbilirubinaemia Aggravated? - 10 seconds ago
- Drug interactions of Cefuroxime Axetil and Pepcid - 12 seconds ago
- Medrol and Transient Ischaemic Attack for Women aged 60+ - 18 seconds ago
- Headache and Urinary Incontinence - 19 seconds ago
- Could Ziagen cause Haematocrit Decreased? - 27 seconds ago
- Hiatal Hernia and Acute Upper Airway Obstruction - 31 seconds ago
- Parnate vs. Adderall 15, side effect and effectiveness comparison - 35 seconds ago
- Could Topamax cause Swelling? - 43 seconds ago